Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Efficacy of Eculizumab

被引：67
|
作者：
El-Husseini, Amr [1 ,2 ]
Hannan, Schot [1 ]
Awad, Ahmed [1 ]
Jennings, Stuart [1 ]
Cornea, Virgilius [3 ]
Sawaya, B. Peter [1 ]
机构：
[1] Univ Kentucky, Div Nephrol, Lexington, KY 40536 USA
[2] Mansoura Univ, Mansoura, Egypt
[3] Univ Kentucky, Dept Pathol, Lexington, KY 40536 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2015年 / 65卷 / 01期
关键词：
Thrombotic microangiopathy (TMA); systemic lupus erythematosus (SLE); eculizumab; kidney biopsy; acute kidney injury (AKI); proteinuria; lupus nephritis; atypical hemolytic uremic syndrome (aHUS); COMPLEMENT INHIBITOR ECULIZUMAB; HEMOLYTIC-UREMIC SYNDROME; THROMBOCYTOPENIC PURPURA; ANTIPHOSPHOLIPID SYNDROME; TERMINAL COMPLEMENT; RECURRENCE; NEPHRITIS; PATIENT;
D O I：
10.1053/j.ajkd.2014.07.031
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Thrombotic microangiopathy (TMA) is a severe disorder with poor outcomes. The cause is unknown for many patients, although TMA is associated with connective tissue disorders, including systemic lupus erythematosus (SLE). While uncommon, TMA is one of the most serious complications of SLE and in many cases may be resistant to therapy. We report a patient with SLE complicated by TMA that was refractory to standard therapy but responded well to eculizumab, with continued remission after 1 year of follow-up. Eculizumab might be useful in the management of resistant cases of TMA caused by SLE. (C) 2014 by the National Kidney Foundation, Inc.
引用
收藏
页码：127 / 130
页数：4
相关论文
共 50 条
  • [1] THROMBOTIC MICROANGIOPATHY AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Arguello Alegre, Maria Laura
    Veronica Marin, Cintia
    De Rosa, Marcelo
    Segovia, Fernando
    [J]. REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2018, 38 (02): : 139 - 147
  • [2] A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
    Rachael D. Wright
    Fariba Bannerman
    Michael W. Beresford
    Louise Oni
    [J]. BMC Nephrology, 21
  • [3] A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
    Wright, Rachael D.
    Bannerman, Fariba
    Beresford, Michael W.
    Oni, Louise
    [J]. BMC NEPHROLOGY, 2020, 21 (01)
  • [4] Plasmapheresis in systemic lupus erythematosus with thrombotic microangiopathy
    Thompson, J. E.
    Jones, J. N.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 (06) : 734 - 735
  • [5] Thrombotic Microangiopathy in the Setting of Systemic Lupus Erythematosus
    Cook, T.
    Fahmawi, Y.
    Hamid, K.
    Almalouf, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [6] A case of thrombotic microangiopathy complicated with systemic lupus erythematosus
    Ohashi, N
    Yamamoto, T
    Kanno, D
    Fujigaki, Y
    Yonemura, K
    Hishida, A
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 326 (02): : 102 - 104
  • [7] SYSTEMIC LUPUS-ERYTHEMATOSUS COMPLICATED BY THROMBOTIC MICROANGIOPATHY
    JAIN, R
    CHARTASH, E
    SUSIN, M
    FURIE, R
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1994, 24 (03) : 173 - 182
  • [8] Eculizumab Is Safe as an Adjunctive Therapy in Systemic Lupus Erythematosus with Severe Refractory Nephritis with or Without Thrombotic Microangiopathy in Children
    Pereira, Maria
    Chun, Angela
    Stubbs, Leigh
    De Guzman, Marietta
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2704 - 2705
  • [9] Thrombotic microangiopathy in Systemic Lupus Erythematosus: three cases report
    Munoz-Grajales, Carolina
    Coronel-Restrepo, Nicolas
    Fernando Pinto-Penaranda, Luis
    Jaime Velasquez-Franco, Carlos
    Dario Marquez-Hernandez, Javier
    [J]. IATREIA, 2018, 31 (02) : 197 - 201
  • [10] RENAL INJURY IN SYSTEMIC LUPUS ERYTHEMATOSUS CHARACTERIZED BY THROMBOTIC MICROANGIOPATHY
    Hu, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1044 - 1044
12345